Lilly cancer drug fails key trial, will no longer be prescribed

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a ...

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Optum to cover Amgen, Eli Lilly migraine drugs, exclude TevaNEW YORK: Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group Inc, has included new migraine drugs from Amgen Inc and Eli Lilly ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Eli Lilly backs US proposal on drug rebates to lower costsEli Lilly and Co on Wednesday embraced a U.S. government proposal to end a decades-old system of rebates drugmakers make to industry middlemen, ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Eli Lilly quarterly sales beat expectationsEli Lilly and Co posted better-than-expected fourth-quarter revenue on Wednesday, helped by higher sales of its newer drugs such as diabetes ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes AmgenCVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AbbVie's cancer drug fails to meet main goal in late-stage studyREUTERS: AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Optum to cover Amgen, Eli Lilly migraine drugs, exclude TevaNEW YORK: Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group Inc, has included new migraine drugs from Amgen Inc and Eli Lilly ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes AmgenCVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »